Aurobindo Pharma’s shares were trading in the red after the company’s subsidiary, APL Healthcare Limited, on 20 September received a ‘Form 483’ with one observation...
Aurobindo Pharma on 17 August announced that it will launch a tablet to treat HIV in low-to-middle-income countries. Headquartered in Hyderabad, Aurobindo Pharma manufactures a...
Eugia Pharma Specialities, a wholly-owned subsidiary of Aurobindo Pharma, on 16 August received approval from the USFDA (United States Food and Drug Administration to manufacture...
Shares of Aurobindo Pharma recovered their initial losses and traded higher at Rs 788.30 at 1:30 pm after the company received three observations from the...
India is set to be one of the world’s best-performing major stock markets this year, defying concerns about rising interest rates and an economic slowdown...